Information  X 
Enter a valid email address
  Print          More announcements

Wednesday 28 April, 2021

JP Morgan Sec LLC

Willis Towers Watson plc 8.3 amend

RNS Number : 9524W
J.P. Morgan Securities LLC
28 April 2021
 

Ap19

 

 

  AMENDMENT

FORM   8.3

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL 1997, TAKEOVER RULES, 2013

 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1.  KEY   INFORMATION

 

Nameofpersondealing (Note 1)

J.P. Morgan Securities LLC

Companydealtin

Willis Towers Watson plc

Classofrelevantsecuritytowhichthe dealingsbeingdisclosedrelate (Note 2)

US$0.000304635 ordinary shares

Date of dealing

26 April 2021

 

2.  INTERESTS AND SHORT POSITIONS

 

(a)  Interests   and   short   positions   (following   dealing)   in   the   class   of   relevant   security   dealt   in   (Note   3)

 

Long

Short

 

Number

 

(%)

Number

 

(%)

(1)Relevantsecurities

1,731,707  1.34

1,658,664  1.29

(2) Derivatives (other than options)

1,518,876  1.18

1,583,623  1.23

(3)Optionsandagreementstopurchase/sell

 

 

Total

3,250,583  2.52

3,242,287  2.52

             

 

 

Ap20

 

 

1.  DEALINGS  (Note   4)

 

(a)  Purchases and sales

 

 

Purchase/sale

 

Numberofrelevantsecurities

 

Priceperunit(USD)

 

(Note 5)

Purchases

 Purchases

 Purchases

 Purchases

 Purchases

 Purchases

 Purchases

 Purchases

 

 Sales

 Sales

 Sales

 Sales

 Sales

 Sales

 Sales

 Sales

 Sales

2

 409

 10

 51

 193

 142

 2

 2

 

 100

 2

 2

 186,908

 10

 99

 6

 386

 2

231.1800  USD

231.3000  USD

232.8900  USD

234.0100  USD

234.0122  USD

234.0130  USD

234.3800  USD

234.3900  USD

 

231.0991  USD

231.1800  USD

231.1900  USD

231.3000  USD

232.8900  USD

233.8000  USD

233.8850  USD

234.0122  USD

234.3900  USD

 

 

 

 

 

 

 

 

 

(b)  Derivatives transactions (other than options transactions)

 

Productname,

e.g. CFD

Natureoftransaction

(Note 6)

Numberofrelevantsecurities

(Note 7)

Priceperunit

(USD) (Note 5)

Equity Swap

Increase Long

186,700

231.3000  USD

 

 

(c)  Options transactions in respect of existing relevant securities

 

 

(i)  Writing, selling, purchasing or varying

 

 

Productname,

e.g. call option

Writing, selling,purchasing,varyingetc.

Numberofsecurities towhichtheoptionrelates (Note 7)

Exercise price

Type, e.g.American,Europeanetc.

Expiry date

Optionmoney paid/receivedperunit (Note 5)

 

 

 

 

 

 

 

 

 

(ii)  Exercising

 

Productname,

e.g. call option

Numberofsecurities

Exercisepriceper unit (Note 5)

 

 

 

 

 

(d)  Other dealings (including transactions in respect of new securities) (Note 4)

 

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

 

 

Ap21

 

2.  OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and any 

other person relating to the voting rights of any relevant securities under any option referred to on this 

form   or   relating   to   the   voting   rights   or   future   acquisition   or   disposal   of   any  relevant securities to which 

any derivative referred to on this form is referenced. If none, this should be stated.

 

  None

 

 

 

 

 

 

 

 

Is a Supplemental Form 8 attached?  (Note   9)    NO

 

Dateofdisclosure

  28 April 2021

Contact name

Alwyn Basch

Telephone number

0207 742 7407

If aconnectedEFM,nameofofferee/offerorwithwhichconnected

N/A

If aconnectedEFM,statenatureofconnection (Note 10)

N/A

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ISEUWRSRAVUSUAR

a d v e r t i s e m e n t